Discussion in 'Too Hot for Swamp Gas' started by 108, Jul 21, 2013.
Now you're coming around.
Perhaps you need to go back and reread what I quoted initially and commented on. I think that is the basis of the misunderstanding. I actually don't think we are far apart here.
As for pharmaceutical rep marketing, of course it isn't benign but it is preferable to marketing to lay persons.
I have no idea what you mean.
I hate all politicians, because all they do is get richer, and make their Ivy league friends richer in the process.
I believe in private property and personal responsibility. I don't see how I'm coming around to anything. There is no evolution to my line of thinking. None.
Agreed. Certainly preferable to consumer marketing.
Just wait until HusseinCare kicks in. Through the roof baby.
I said that they were dishonest and misleading about where their costs are, you seem to be implying that I said that they shouldn't be spending on marketing. Or did I misread you?
The initial data is not showing that. In fact, it is showing a considerable rate decrease compared either to the plan with a growth rate based on premium growth rates prior to ACA or even when compared to prior government projections.
Early indications from my company (largest of our kind in the NW) are pointing the other way. I'll be curious to see what we negotiate since we have some leverage and use two different insurers.